Neostigmine Methylsulfate Injection Market Is Estimated To Witness...

ha aggiunto un file Health

2023-11-22 11:40:57 -

Neostigmine Methylsulfate Injection Market Is Estimated To Witness High Growth Owing To Increasing Prevalence Of Myasthenia Gravis

The Neostigmine Methylsulfate Injection Market is estimated to be valued at Us$ 156.75 Mn or in 2023 and is expected to exhibit a CAGR Of 4.5% over the forecast period 2023 To 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Neostigmine methylsulfate injection is used for the treatment of myasthenia gravis, which is an autoimmune neuromuscular...

0 Commenti 0 condivisioni 743 Views 0 Anteprima